Subject: Re: BRK: Why Not XOM?
My oh my oh my oh my
What to do, what to do, what to do

Etrade analyst ratings:
1 buy
4 hold
3 sell
Average predicted 12 month price: $131, +20%


Fidelity "Opinions & reports" ratings:
1 sell
6 Neutral

Fidelity "other opinions":
7 buy/outperform
3 Neutral

"ARGUS RATING: BUY
• Recent price weakness offers buying opportunity"
Report at 118, currently 108